Article Details

Paradigm Biopharmaceuticals (ASX:PAR) submits IND to US FDA

Retrieved on: 2021-03-26 00:44:49

Tags for this article:

Click the tags to see associated articles and topics

Paradigm Biopharmaceuticals (ASX:PAR) submits IND to US FDA. View article details on hiswai:

Excerpt

Paradigm Biopharmaceuticals (PAR) has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) ...

Article found on: themarketherald.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up